
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+5
Yokogawa Insilico Biotechnology GmbH delivers predictive Digital Twins for the biopharmaceutical industry. Insilico Digital Twins lead to superior productivity, product quality and process robustness by using artificial intelligence and mechanistic knowledge. As a result, Insilicos unique approach substantially reduces costs of manufacturing and time to market. Leading biopharmaceutical companies worldwide use Insilico Digital Twins for process development and manufacturing of drugs. Founded in 2001, Insilico Biotechnology is a privately held company based in Stuttgart, Germany
Cell line engineering,bioprocess engineering,metabolic modeling,upstream process,metabolic engineering,cell culture,life sciences,biologics,software development,and data visualization
Yokogawa insilico biotechnology gmbh operates in the Biotechnology research industry.
Yokogawa insilico biotechnology gmbh's revenue is 11m - 100m
Yokogawa insilico biotechnology gmbh has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.